MYECO GROUP LTD — Board/Management Information 2018

Jul 15, 2018

==> picture [103 x 41] intentionally omitted <==

ASX RELEASE

16 July 2018

Non-Executive Director appointment strengthens SECOS Board

Highlights:

• SECOS appoints internationally experienced plastics industry veteran David Wake as Non-Executive Director

• Mr Wake brings a stellar track record of unlocking shareholder value and an ability to contribute to the Company’s global ambitions

• Mr Wake makes a $150,000 investment in the Company via a share placement to establish an initial director interest

Sustainable and eco-friendly bioplastics developer SECOS Group Limited (ASX: SES, “SECOS” or “the Company”) is pleased to announce that it has appointed seasoned business finance and change management professional David Wake as a Non-Executive Director of the Company, effective 16 July 2018.

Mr Wake brings valuable commercial experience from a number of senior executive positions in the global plastics industry, which will inform and support the Company’s international growth strategy. Mr Wake has a 30-year record of accomplishment in driving shareholder value through organic growth as well as large and small-scale M&A transactions.

SECOS Chairman, Richard Tegoni, welcomed the appointment, stating:

“We are thrilled to have attracted David to join the SECOS Board. He brings a wealth of industry knowledge and deep practical experience which will strengthen the Company as our expansion plan moves to the next phase of its development.

“What makes David a perfect fit is his combination of plastics industry experience, depth of network in the international corporate arena and his proven track record of managing people and businesses through development and change. We are pleased to welcome David to the SECOS Board.”

Mr Wake brings meaningful global business experience and has held a number of positions in the US at Imperial Chemical Industries’ (ICI) multi-billion-dollar specialty chemical subsidiary, National Starch and Chemical Co, including Finance Director for the Specialty Synthetic Polymer division, Senior Director of Financial Planning & Reporting, and ultimately Vice President Finance in the company’s New Jersey head office. He also spent two years in London at ICI’s global headquarters as Director of Strategy and Performance.

Following ICI’s acquisition by Akzo Nobel, Mr Wake joined polymer banknote company Securency as Chief Financial Officer based in Melbourne. At Securency, he planned and executed a new strategic direction for the company, culminating in its successful reorganisation into the Innovia Group and subsequent sale to CCL Industries of Toronto.

SECOS Group Limited (ASX: SES) ACN 064 755 237 Level 2, Suite 6, 205-211 Forster Road Mount Waverley VIC 3149 Australia t: +613 8566 6805 e: info@secosgroup.com.au www.secosgroup.com.au

==> picture [103 x 41] intentionally omitted <==

The Company is pleased to report that after extensive due diligence, Mr Wake has invested $150,000 in the Company via placement of 2,000,000 new shares at $0.075 per share, a 15% discount to the 5-day volume-weighted average price. This price is consistent with terms associated with previous offerings and Convertible Note placement

The placement shares will be issued under the Company’s ASX Listing Rule 7.1 placement capacity, subject to receiving shareholder approval at the Annual General Meeting. The funds raised will be used to fund additional working capital as SECOS addresses new demand for bioplastic resin in international markets.

Please find attached an Appendix 3X – Initial Director’s Interest Notice relating to Mr Wake’s appointment.

For more information, please contact:

Richard Tegoni Executive Chairman +61 411 110 901 r.tegoni@secosgroup.com.au

Tim Dohrmann Investor and Media Enquiries +61 468 420 846 tim@nwrcommunications.com.au

About SECOS Group Limited

SECOS Group Limited (ASX: SES) is a leading developer and manufacturer of eco-friendly bioplastic materials. Based in Melbourne, Australia, SECOS supplies its proprietary biodegradable resins, packaging products and high-quality cast films to a blue-chip global customer base.

SECOS holds a strong patent portfolio and the global trend toward sustainable packaging is fueling the Company’s growth, bringing FY17 revenue of $22 million.

The Company’s headquarters and Global Application Development Centre are based in Melbourne, Australia. SECOS has a Product Development Centre and manufacturing plant for resins and finished products in Nanjing, China, with manufacturing plants for high quality cast films in Melbourne and Kuala Lumpur, Malaysia. SECOS’ annual production capacity is 7,200 tonnes of bioplastic resins, 15,000 tonnes of cast film and 2,000 tonnes of blown film and finished products.

SECOS has sales offices in Australia, Malaysia, China and the US, with a network of leading distributors across the Americas, Asia and Europe.

SECOS Group Limited (ASX: SES) ACN 064 755 237 Level 2, Suite 6, 205-211 Forster Road Mount Waverley VIC 3149 Australia t: +613 8566 6805 e: info@secosgroup.com.au www.secosgroup.com.au

Appendix 3X Initial Director’s Interest Notice

Rule 3.19A.1

Appendix 3X

Initial Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/9/2001.

Name of entity	SECOS GROUP LIMITED
ABN	89064755237

We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	David Wake
Date of appointment	16 July 2018

Part 1 - Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

2,000,000 Ordinary Shares

• See chapter 19 for defined terms.

11/3/2002

Appendix 3X Page 1

Appendix 3X Initial Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of Number & class of Securities interest Note: Provide details of the circumstances giving rise to the relevant N/A interest.

Part 3 – Director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder(if issued securities)	N/A
No. and class of securities towhich interest relates	N/A

• See chapter 19 for defined terms.

Appendix 3X Page 2

11/3/2002